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A. Hy datidiform Mole*
Hydatidiform mole is a placental disorder which arises in early
pregnancy and takes the form of clusters of transparent or semi-trans-
parent vesicles ranging from 3 to 10 mm in diameter, but vesicles as
small as a pinhead or as large as a hen's egg are not at all rare. The
mole is marked with hydatidiform swelling of its villi and variable
trophoblastic proliferation. The conceptus may be retained in utero
for up to twenty weeks and the longer it is retained the greater is
the degree of hydropic swelling. The molar villi arise from the
chorionic membrane to which the vesicles can be found attached by tenuous
thread-like remnants of the villous stem. Decidual tissue and blood
clot can often be found in between the vesicles. Hydatidiform mole is
believed to be a foetal defect and not due to maternal endocrine
imbalance as vesicular mole has been found in only one ovum in multiple
pregnancies (Hertig, 1968).
A benign mole is characterised by a well-preserved villous pattern,
oedema and degeneration of stroma, a scantiness of blood vessels, a
considerable degree of trophoblastic activity with no evidence of
anaplastic cell changes, and a lack of tendency to penetrate into the
stroma. Occasionally the trophoblastic epithelial cells become malignant,
invade the uterine muscle, and metastasise by the blood stream.
The sequence of events leading to the formation of hydatidiform mole
may be:
(1) the early death or absence of an embryo,
*There are several general references which merit special mention:
Borell et al., 1966 Haines and Taylor, 1962 Hertig, 1968 and Novak
and Woodruff, 1974.
(2) the disappearance of villous blood vessels,
(3) the accumulation of stromal fluid through the activity of a still
functioning trophoblast« and
(U) the ultimate globular swelling of the branches of the involved villus.
Hydropic swelling per se is not a pathologic process j it is due toKJ ~ «--ar-3WU«
the persistence of normal activity in the immature trophoblast in the
absence of a functioning chorionic circulation and fluid elaborated by
the trophoblast accumulates in the stroma of the villi (Sciarra, 1970).
The molar trophoblast is physiologically similar to that of the youngV
chorion and it is able to concentrate substance in strengths different
from that in the maternal circulation.
Wide variation exists among the incidence of hydatidiform moles
which seems to depend on geography (Tan and Lean, 1972), It is highest
in the Far East, being 1 to 2p2 deliveries in Hong Kong (Chun et al..
196Ii) and 1:126 in Manila (Acosta-Sison, 19u9), and lower in the western
countries: 1:2,000 in Europe (Shaw, 1971; Jeffcoate, 196?), and 1:1,000
to 1:2,000 in America (Logan and Motyloff, 1958)
The usual symptoms.of hydatidiform mole are vaginal haemorrhage
during early pregnancy (2nd to 5th months), enlargement of the uterus
beyond the size expected from the assumed duration of pregnancy,
abdominal pain, albuminuria, hypertension, and occasionally sepsis
(Curry et al., 1975)
Diagnosis is based on the presence of vesicles in vaginal discharge,
the absence of foetal heart sound and foetal movements, the failure to
palp ate foetal parts at the time when these are normally present, bilateral
theca lutein cysts, araniography, sonography (Curry et al., 1975; Delfs,
1975)) and an elevated level of urinary human chorionic gonadotrophin
(HCG) which may amount to 2,000,000 i.u. per litre (Brinck-Johnsen and
3Bonirschke, 1968). This value of urinary HCG is only occasionuo lly found
in normal pregnancy and then usually with multiple pregnancies. The high
HCG titre usually leads to the common complication of multiple bilateral
theca lutein cysts of the ovary as a result of stimulation by HCG from the
trophoblast, being, as it were, an autonomous Aschheim-Zondek test.
The chemical composition of the fluid from hydatidiform mole villi
was studied by McKay et al. (1955, 1958). In this laboratory molar HCG
was isolated in pure form by Chan (1973) and Chan et al. (1974) and the
properties of HCG isolated from molar tissue and normal pregnant urine
were investigated by Fung (1975). In view of the quantitative and qual-
itative differences in molar and placental HCG and the general opinion
that HCG keeps the corpus luteum functional until the steroid hormones
required for the development of the conceptus are produced in adequate
amounts by the foetoplacental unit (Borth, 1971), it is therefore important
to compare the levels of oestrogens and progesterone in molar and placental
tissues.
An immediate result of the high level of HCG in molar pregnancy is
an elevated serum level of oestradiol (Dawood et al., 1974) and progesterone
(Teoh et al., 1972 Dawood, 1974). They explained that the molar tissue
acts as a secondary source of steroid production under the action of HCG.
In order to gain a better insight into the action of HCG on hydatidiform
mole and a better understanding of the aetiology of this placental disorder,
a knowledge of the levels of the oestrogens and progesterone is very
valuable.
Studies of oestrogen concentration in molar tissues have not been
reported in the literature except for that of Chamberlain et al. (1968)
who used gas-liquid chromatography and could only find trace amounts
of oestriol in hydatidiform mole their result on this particular hormone
was not given in quantitative terms. The molar concentration of progester¬
one has been reported by Chamberlain et al . (1968) and Dawood et al. (197$).
The former used gas-liquid chromatography and found a lower concentration
of progesterone in molar tissue than in normal placenta. The latter used
competitive protein-binding analysis (ibid.) and discovered that the molar
concentration was about eight times the placental (Table 2). They explained
that in the absence of a circulation, the progesterone synthesised by the
molar tissue accumulated inside the vesicles to build up a high concentration.
This is altogether probable since studies on steroid biosynthesis in molar
tissue have shown that the molar tissue has the same capability of synthe-
sising progesterone as the placenta provided the necessary precursors are
made available (Vide infra). If the degeneration of the circulatory
system in hydatidiform mole leads to accumulation of progesterone, the same
cause would result in a reduction of the supply of raw materials for bio¬
synthesis and hence a low rate of output, contrary to their hypothesis
that the molar tissue is a secondary source of progesterone. It is
anticipated that the cholesterol levels in hydatidiform mole and placenta
may give a clue to the actual underlying cause since it is the precursor
of both the oestrogens and progesterone.
The present investigation therefore aims to study more fully the
concentrations of oestrogens and progesterone in molar tissues. Radio¬
immunoassay was chosen because it was more sensitive, capable of determining
steroids at very low levels in tissues, and was more specific. It is
hoped that a knowledge of the levels of the oestrogens and progesterone
in hydatidiform mole may help to give a better understanding of the
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B. Biogenesis of Oestrogens
In order to understand the endocrinological alterations during
pregnancy and the differences between normal and molar pregnancies, the
metabolic pathways for the synthesis and metabolism of the oestrogens
and progesterone will be described in some detail.
More than twenty (22) oestrogens have been found in the urine of
pregnant women (Beling, 1971; Klopper, 197U), but the data obtained to
date are mostly concerned with the three classical oestrogens, viz.:
oestrone (3-hydroxyoestra-1,3,5(10)-trien-17-one, E), oestradiol
(oestra-1, 3,5 (10)-triene-3,1 73-diol, E2), and oestriol (oestra-1,3,5(10)-
triene-3 16u, 1 73-triol, E ) •
The biogenesis of steroids begins with the two-carbon fragment,
acetate, goes through the intermediates mevalonate, squalene,and lario-
sterol, and culminates in the 27-carbon steroid, cholesterol (cholest-5-
en-33-ol), from which all other steroid hormones are made. However it
is shown that the mid-gestation placenta by itself is not capable of
1 !i
converting C-labelled acetate to squalene or lanosterol (Van Leusden
et al., 1971) or to cholesterol (Telegdy ejb al., 1970) and the term
placenta has but limited capacity for the de novo synthesis of cholesterol
(Zelewski and Villee, 1966), but such conversions are readily carried
out by the entire foetoplacental unit. The major source of cholesterol
is the foetal liver (Telegdy et al., 1970) although contributions are
also made by the maternal circulation, which has a high cholesterol
concentration at this stage of life (Ma et al., 1965).
The first step in the synthesis of steroid hormones is the enzymatic
degradation of the side chain at C — 17 of cholesterol (Fig. 1). The
result is the 21-ca.rbon steroid, pregnenolone (33-hydroxypregn-5~en-20-one)
Now the tide turns. Significant amounts of pregnenolone are made by the
placenta but the foetus is unable to carry out this synthesis. Hence
it is altogether fitting and proper to regard the foetus and placenta
as a whole, each dependent on the other (Diczfalusy, 196)4)- the foetus
turns out cholesterol and passes it to the placenta which converts it to
pregnenolone. From pregnenolone on, the road branches and, depending on
the pathway taken, one arrives at the oestrogens, progesterone, the
androgens, or the corticosteroids (Dorfman and Sharma, 1965).
The once generally held concept that the placenta is the source of the
large amounts of urinary oestrogens during pregnancy was overthrown by
Cassmer (1959) when he discovered that the placental capacity to synthesise
oestrogens diminished tremendously when the foetal circulation was obstruct¬
ed by a knot tied in the umbilical cord, Frandsen and Stakemann (1962)
showed that oestrogenic activity was obatined only when portions of
foetal adrenal and placenta were implanted together into spayed mice
and no oestrous vaginal smears could be obtained when portions of these
tissues were transplanted separately. This finding shows that the foetal
adrenals and the placenta are necessary for oestrogen biosynthesis although
the possible involvement-of other tissues such as the liver is not excluded.
The foetal adrenals maintain a high concentration of dehydroepiandro-
sterone (33-hydr oxyandr ost -5-en- 1 7-one , DHEA) in the foetus and mother.
DHEA is of particular interest because of its multiple precursor role in
the synthesis of the placental oestrogens. It is synthesised from 1 fu¬
lly droxypregne nolone (33.1 la-dihydroxypregn-$-en-20-one ) sulphate, which
in turn is produced by hydroxylation and. sulphurylation of pregnenolone.
Sulphate conjugation takes place in the foetal liver which possesses a
high sulphurylating capacity. Siiteri and MacDonald (1966) showed that
approximately equal amounts of DHEA were produced by the foetal and maternal
sides. DHEA is abstracted by the placenta for oestrogen synthesis as shown
by an arteriovenous difference of 30 fig per 100 ml in the umbilical
circulation. The steps in the course of oestrogen synthesis are therefore
17a-hydroxylation of pregnenolone, formation of DHEA' by removal of the
two-carbon side chain, hydroxylation at C — 19 and aromatisation of ring
A. Removal of the two-carbon side chain takes place in the foetus under
the action of desmolase. Foetal desmolase does not possess the ability
to remove the two-carbon side chain of C-21 steroids like progesterone,
which has a A -3-ketone structure, but precursors like pregnenolone or
3
17a-hydroxypregnenolone with a A -35-hydroxy structure are readily trans-
formed into DHEA by the foetal adrenal. The remaining two steps, hydroxyl-
ation at C — 19 and aromatisation of ring A, are carried out rapidly and
efficiently by the placenta.
Of the oestrogens found in the foetoplacental unit, oestriol deserves
special mention. It is characterised by having a hydroxyl group at C-16
of the molecule, the insertion of which takes place mainly in the foetal
liver. 16-Hydroxylation in the foetus can take place earlier in the
biosynthetic sequence; in fact, the hydroxyl group may be inserted in
such early molecules as pregnenolone or in the C-19 compounds like DHEA.
This is probably the rate-limiting step and represents a means of disposal
of potent oestrogens within the foetoplacental unit.
The other two oestrogens, oestrone and oestradiol, are mainly
synthesised in the placenta by converting DHEA to oestrone. In molar
pregnancy, the foetal supply of precursor DHEA is absent, but the
production of oestrone remains the same (Siiteri and MacDonald, 1966).
Probably the maternal circulation provides the necessary precursors.
Thus urinary oestriol of pregnant women stems from two sources: a bio¬
synthetic product of the foetus and a metabolite of oestradiol. Rate-
limiting processes appear to reside in the 16-hydroxylation step, which
leads only to oestriol, or in the aromatisation of ring A, which leads
to both oestradiol and oestriol. 16-Hydroxylation is under foetal control
while aromatisation is under placental control.
»
It was mentioned in p. 7 that an interruption in the foetal connection
results in a sudden drop in the excretion of oestrogens by the mother.
%
Hydatidiform mole bears resemblance to this condition in that there is
no circulation in the chorionic villi and the foetus is absent. Foetal
tissues are implicated in the synthesis and conjugation of oestriol, and,
although the syncytial elements appear abundant,, this does not mean that
they possess intact enzyme systems as in the normal placenta (Taylor et al.,
1965a). Steroidogenesis in hydatidiform mole has been explored in in
vitro incubation studies (Van Leusden and Villee, 1966; Houtzager ert al.,
1970; Van Leusden and Siemerink, 1969; Coutts and Macnaughton, 1971). The
data concerning the formation of oestrogens by hydatidiform mole agree
very well with the conversion of C — 19 steroids to oestrogens in preparations
of placenta of normal pregnancies (Ryan, 1959)- Pregnenolone is not metab¬
olised into oestrogens in the molar compartment, but major quantities of
DHEA or its sulphate are converted into oestrone and oestradiol (but not
into oestriol) (Barlow et al., 1967; Van Leusden and Villee, 1966). These
and the observati n that DL-Jjj- Hi]-mevalonate is not incorporated into
cholesterol or oestrogens (Van Leusden and Villee, 1966) indicates that
oestrogens are not produced de novo in hydatidiform moles. Since DHEA
sulphate is incorporated into oestrogens, molar tissue, like normal placenta,
is rich in sulphatase activity (Van Leusden and Villee, 1966). Thus the
molar compartment can utilise DHEA sulphate for oestrogen production in vivo.
Siiteri and MacDonald (1966) showed that DHEA sulphate served as a precursor
of a large proportion of oestrogens produced in vivo by a patient with a
hydatidiform mole.
Results of in vitro incubations are in agreement with in vivo findings.
After the administration of labelled 17f-oestradiol to patients with
hydatidiform moles, the specific activity of oestradiol excreted is 68 to
87 per cent that of the oestrone or oestradiol. In contrast, only 10 per cent
of the oestriol in late pregnancy arises from the catabolism of oestrone
and oestradiol in the maternal compartment (Fishman et hi., 1962; Gurpide
et al., 1962). The urinary oestriol in molar patients is derived from the
catabolism of oestrone and oestradiol in the maternal compartment. Maternal
DHEA or its sulphate can serve as precursors of oestrone or oestradiol in
hydatidiform moles. A decrease in the urinary excretion of oestrone,
oestradiol, and oestriol of 77, 79? and 89 per cent respectively after
the administration of 9n-fluoro-l6a-methylprednisolone to a molar patient
showed that the DHEA (sulphate) may be of maternal origin (Van Leusden, 1972)
In hydatidiform mole Wei et al. (1968) found lower oestriol excretion
values than that for the appropriate stage of pregnancy. Macnaughton. (1969)
and Brown et al. (1970) found that the excretion could be equal to that
of normal pregnancies of a comparable duration. Acevedo et al . (1970)
found low values corresponding to that encountered in foetal death.
Other investigators (Payne, 19i|1j Bonnano et al., 1963) found greaterMMrannwinw|i
oestriol excretion by women with hydatidiform moles. After evacuation of
the molar tissues the level may remain elevated for several weeks or there
may be an immediate fall.
In hydatidiform molo the ratio of oestriol to oestrone plus oestradiol
is similar to that of non-pregnant women (Van Leusden, 1972). The source
of oestriol is therefore suggested to be the often hyperstimulated
ovaries and not the molar tissue itself. Siiteri and MacDonald (1966)
found that in six women with hydatidiform moles, the rate of production
of oestradiol during the 12th to the 19th weeks of pregnancy was 2 to 11
11
mg per day, and the amount of oe str adiol in four ol these patients was
comparable to that found during the third trimester of pregnancy.
Chamberlain et al. (1963) found that oestriol was present in very
minute quantities in molar tissue and the level was lower than the value
in placental tissues of an equivalent age as reported by Dicz-fi'alusy et al.
(1961). Oestrone and oe stradiol were within the limits found in normal
placentae (25 to 200 yg per kg in each case).
Dawood et al. (1974) found a higher level of serum oe stradiol in
hydatidiform mole than that of normal pregnancy of a comparable du_r. action.
The source of this oestrogen is probably the ovaries which are often







Fig. 2. Biogenesis of progesterone and related steroids in the foeto-
placental unit (Klopper, 197Uj Solomon and Fuchs, 1971)
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C. Biogenesis of Progesterone
During the initial stage of pregnancy the corpus luteum is the main
source of progesterone (pregrl-Li--ene-3,20-dione). Prodi-Lction of progesterone
is stimulated by HCG and, during the initial stage of pregnancy, the plasma
level of progesterone parallels that of HCG (Yoshimi et al., 1969).
Although the corpus luteum persists throughout pregnancy (Zander et al.,
1958). the placenta.begins to take over the task of progesterone production
from 3 to 6 weeks the corpus luteum is no longer necessary for the main-
tenance of pregnancy and oophorectomy does not always lead to abortion
(Davies and Ryan, 1972 Diczfalusy and Borell, 1961 Rebbe and Moller, 1966).
The time of take-over can be estimated by studying the concentration of
progesterone and 17a-hydroxyprogesterone (17a-hydroxypregn-)4-ene-3, 20-dione)
during early pregnancy. Both of these progestogens reach a peak concen-
tration 3 to 4 weeks after ovulation. Then both begin to fall but plasma
progesterone concentration reaches a nadir at 6 to 8 weeks and increases
again while that of 17a-hydroxyprogesterone continues to decline (Yoshimi
et al., 1969). Since the Corpus luteum has but limited capacity for 17a-
hydroxyprogesterone, the second rising phase in the progesterone curve is
a reflection of placental function.
The human term placenta has but limited capacity for the de novo
synthesis of cholesterol under in vitro conditions (Zelewski and Villee,s
1966). The large amounts of cholesterol required for t iTe synthesis of
neutral steroids (Fig. 2) are probably provided by the mother. This C-27
steroid is transformed into pregnenolone and progesterone by the placenta
(Morrison et al., 1965 Solomon, 1960). In fact, maternal cholesterol is
very efficiently converted to urinary pregnanediol( 5-pregnane-3p, 20a-diol)
during late pregnancy (Bloch, 1945). The foetus is capable of transforming
pregnenolone into other steroids but it appears to be lacking in the 3p-
hydroxysteroid. dehydrogenase system required for the conversion of preg¬
nenolone to progesterone. Measurement of the metabolic clearance rate injl —•
various subjects showed that only with pregnant females was the claculated
production rate similar to the observed production rate. This shows that
progesterone is metabolically the most important precursor of urinary
pregnanediol in late pregnancy (Arcos et al.. 196k).
Determination of the arteriovenous difference in progesterone levels
in the umbilical cord shows that the foetus can metabolise 30 to 1;0yug of
progesterone for every 100 ml of plasma reaching the placenta (Harbert et
al., 196k). In order to find out the tissues in which metabolism occurs,
Solomon (1966) and Solomon and Fuchs (1970 infused {_ k-c]progesterone
into the umbilical vein of an intact foetus and placenta at mid-gestation.
The metabolites were then isolated from the various foetal tissues and
the least amount of progesterone was recovered from the adrenals and
liver, showing that these tissues were active sites of progesterone
metabolism. He also showed that in the intact foetoplacental unit, preg-
nanediol was formed in the liver and then transported to other tissues.
20a-Dihydroprogesterone (20c?-hydroxypregn-k-en-3-one) was ubiquitously
found in all foetal tissues except the thyroid. Infusion of human mid-
gestation placenta with labelled progesterone and 20cz-dihydroprogesterone
showed that an appreciable conversion of 20z~dihydroprogesterone took
place but the reverse reaction, ie., the conversion of progesterone to
20a~dihydroprogesterone barely proceeded. It can be said that progesterone
elaborated in the placenta is transported to the foetus where the foetal
tissues reduce it to 20-dihydr oproge sterone. The reduced metabolite is
oxidised to progesterone when it reaches the placenta. This reversible
pathway existing in the two compartments of the foetus and placenta may be
a contrivance by which progesterone is conserved in the foetoplacental
unit (Solomon and Fuchs, 1971).
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Pregnenolone and progesterone formed from cholesterol in the human
placenta( Morrisonet al . , - 1905 Solomon, 1960 ) can reach the foetus under
normal conditions . Solomon and Fuchs ( 1971 ) therefore investigatedthe
metabolismof pregnenolonein the foetoplacentalu it using [ 4 - 14 C ] preg -
nenolone. A 4 - 3 - Ketone metaboliteswere isolated only from the placenta ,
showing that 3 p - hydroxysteroiddehydrogenasewas absent in foetal tissues
at mid - pregnancy. 16 a - Hydroxypregnenolone( 313 , 16 a - dihydroxypregn- 5 - en -
20 - one ) was found in the liver only , demonstratingth t 3 - hydroxy- o 5 -
steroids were 16 - hydroxylatedby this tissue . This 16 a - hyxroxylationof
C - 21 steroidswith a A 4 - 3 - ketone takes in the foetal place adrenalswhile
16 a - hydroxylationof C - 19 and C - 21 steroidswith 3 p - hyxroxy- A 5 grouping
occurs in the foetal liver . If the labelled pregnenoloneis replaced by
[ 7 a - 3 H ] pregnenolonesulphate' , less radioactivityy is found in the . maternal
urine . This indicates that pregnenolonein its unconjugatedform enters
the maternal circulation more readily than the conjugated . Pregnenolone
sulphate was isolated from all foetal tissues , showing that they - were
devoid of steroid sulphatase activity , in agreement with the findings of
French and Warren ( 1965 ) . From placental tissue , pregnenolonesulphate ,
pregnenolone, progesterone, and 20 a - dihydroprogesteronewer isolated .
These imply that most of the pregnenolonesulphate reaching the placenta
from the foetus is hydrolysed to pregnenolonewhich is then converted to
progesteroneand 20 a - dihydr • oprogesterone.
The most important metabolic pathway in the pregnant woman is the
formation of pregnanediolfrom progesteroneand 20 c , - dihydroprogesterone.
Pregnanediolis excreted in the urine and the bile . The urinary excreta
is in the form of the 3 - glucurorlate.
In hydatidiformmole Macnaughtonand Greig ( 1965 ) and Coutts et al .
( 1968 ) 1969 ) found that the conversionof progesteroneinto pregnanediol
16
was about 2 : 11 whereasin normalpregnancy, the ratio was 20 : 1 . Payne ( 10 ) i l
Coutts et al . ( 1968 , 1969 ) , Van Leusdenand Siemerink( 1969 ) , and cevedo
et al . ( 1971 C ) found increasedpregnanetriol( 5 - pregnane- 3 , 17 a , 20 a - triol )
excretion in molar patients . The excretion remains high after evacuation
of the uterus indicating that the pregnanetriolis of ovarian origin
( Stitch et al . , 1966 ) . The pregnanedioJ_ excretionis usually but not
invariablylow ( Yacnaughton, 1965 Brown et al . , 1970 ) . Evacuation
results in an immediate fall in pregnanediolexcretion in about 40 % of
the patients the remainder may show an elevated level for up to sever ,
weeks ( Broeb et , al . , 1970 ) . Chamberlaint al . ( 1968 ) found lower concen-
trations of progesteronein moles than in normal full term placentae ,
but Dawood et al . ( 1975 ) discoveredthat the molar progesteroneconcentra-
tion was several times that of the placental .
Kolar tissues incubated with labelled acetate failed to incorporate
the radioactivity into pregnenolone and progesterone ( Van Leusden and
Villee , 1966 Van Leusden and Siemerink, 1969 ) . These authors also dis -
covered that incubationof molar vesicles with [ 7 - 3 H ] pregnenolone, radio - -
I.
active progesteroneand 17 a - hydroxypregnenolonewere produced . Coutts and
Macnaughton( 1971 ) found that molar tissues synthesised17 a - hydroxypreg-
nenolone , progesterone, 16 a - hydroxyprogesterone, . and 16 - hydroxyproesterone
from labelled pregnenolonein vitro . 17 a - Hy drox 3 progesteronewas . not
found although this compound could be recovered from theca lutein cyst
fluid . These data also suggest that urinary pregnanetriolis probably
of ovarian origin .
The serum level of progesteroneis higher in molar pregnancy than
in normal pregnancy( Teoh et al . , 1972 Dawood, 1971 . ) . The molar
vesicles and the ovaries may be held responsiblefor this enhancement.
Thus molar pregnancy is accompanied by gross endocrine disturbances
17
manifested as changes in oestrogen, progestogen, and. HCG output. The
quantitative differences of oestrogens and progesterone between molar
and placental tissues are therefore investigated in the present study
MATERIALS AND METHODS
A. Determination of Antiserum Titre
The antiserum titre was assessed by determining the ability of the
antiserum, to bind radio-labelled steroid at various dilutions in the
absence of unlabelled antigen (Cameron and Scarisbrick, 1973). The
appropriate dilution is the one that will bind about one half of the
radio-labelled antigen.
(1) Materials
[6,7(n)-Hl Oestradiol (specific activity 1|8 Cimmol) and 1,h-bis[2-
(9-phe nyloxa s o lyD] -benzene (POPOP) were obtained from New England Nuclear
3
Corporation, Boston, Massachusetts, U.S.A. [l,2,6,7(n)~ H]Progesterone of
specific activity 82 Cimmol was obtained from the Radiochemical Centre,
Amersham, Buckinghamshire, Gt. Britain. Dextran, gelatin, sodium azide,
and Triton X-100 were obtained from Sigma Chemical Co., St. Louis, Missouri,
U.S.A.. Scintillation grade toluene wa from E. Merck, Darmstadt, Germany.
Sodium chloride, AnalaR grade, was from British Drug Houses Ltd., Poole,
!
Dorset, Gt. Britain. Norit-A was of pract. grade and was obtained from
Serva Feinbiochemica GmbH and Co., Heidelberg, Germany. Antibodies to
oestradiol and progesterone were obtained from Calbiochem, La Jolla,
California, U.S.A. 2,5-Diphenyloxazole (PPO) was supplied by Packard
Instrument Pty., Ltd., Melbourne, Australia.
(2) Reagents
(a) Phosphate-buffered saline (PBS), 0.1 M, pH 7.0, was prepared from 9»k g
of NaHPO.HO, 21.9 g of NaHPO. 12H0, 9-0 g of sodium chloride, 1.0 g
of sodium azide, and 1 litre of glass-distilled water.
(b) Dextran-coated charcoal suspension (DCC). 29 rng of dextran and 100 mg
of gelatin were dissolved in 100 ml of PBS and 250 ing of Norit-A were
added. The charcoal was maintained in suspension with a magnetic
stirrer during use.
(c) Gelatin solutions (0.1$ (wv) (assay buffer), and 0.5$ (wv) were
prepared by adding 100 mg and 500 mg of gelatin respectively to 100 ml
of PBS.
(d) Radio-labelled antigens. Aliquots of tritiated oestradiol and tritiated
progesterone solutions were evaporated to dryness and re-dissolved in
assay buffer to make a concentration of 10,000 to 15,000 c.p.m. per
100 1.
(e) Toluene-Triton X-100 scintillant. U g of PP0, 0.2 g of P0P0P, 667 ml
of toluene, and 333 ml of Triton X-100 (Price, 1973; Turner, 1971)
Reagents (a) through (d) were stored at h°.
(3) Antibody Solutions
The antibodies obtained in lyophilised form were dissolved in 1 ml
of distilled water, snap frozen in small portions in 1-ml serum vials,
and stored under deep freeze. Before use, the required amount of anti¬
serum solution was thawed and serially diluted with ice-cold assay buffer.
(U) Method
The determination was carried out in duplicate as illustrated in tie
following table (p. 20). A series of 10 x 75 mm test-tubes were set up
and 100 1 of anti-oestradiol or anti-progesterone at various dilutions
were added. One hundred 1 of the appropriate radio-labelled antigen solu¬
tion were added to each sample-blank. The tubes were incubated at I4.0 for
16 hours. Two additional test-tubes containing 1.1 ml of assay buffer and





















'100 ill unless otherwise stated
the totals. In another two, the blanks, antiserum was replaced by
100 ul of assay buffer. At the end of the incubation period, 100 I of
Q.%% gelatin solution were added to all the tubes and agitated. One ml
of DCC was added to all the tubes except the two totals and was immed¬
iately agitated for 5 seconds. After standing in ice-water for 10 minutes,
the tubes werecentrifuged in a refrigerated centrifuge (Sorvall RC2-B, Iva
Sorvall, Inc., Newtown, Connecticut, U.S.A.) at 3,000 x g for 10 minutes.
One ml of the supernate was transferred to a counting vial, the toluene-
Triton X-100 scintillant was added, and the radioactivity was' determined
with a liquid scintillation counter (Nuclear Chicago Mark I, G. D. Searle
(Nuclear Chicago), Des Plaines, Illinois, U.S.A.).
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B . Determinationf Incubation Time
The literature related to radioirrrmunoassaymethodology suggests the
use of considerably varied combinations of incubation tirries . The incubati
time appropriate for the present study was therefore determined ( Lenz et
al . , 1975) .
( 1 ) Materialsand Reagents
The materialsand reagentsu : ( Jd were the same as those listed in
pp . 18 and 19 .
( 2 ) AntibodySolutions
The frozen oestradii _ ol and progesteroneantisera ( p . 19 ) were thawed
and diluted with 60 and 50 volumes ' respectivelyof ice - cold assay buffer .
( 3 ) Method
The radio - - labelled antigen was mixed with an equal volume of the corr .
espondingantibody solution at 4 ° . Two hundred - ul aliquots were trans -
ferred at intervalsto 10 x 75 mm test - tubes containing100 ul of 0 . 5 %
gelatin so lotion . The - tubes ( sample - blanks ) were agitated. One ml of
DCC was added and the contents were mixed for 5 seconds . The tubes were
allowed to stand in ice - water for 10 minutes and then centrifugedat 3 , 000
x g for 11 minutes in a refrigeratedcentrifuge. One ml of each superna to
was placed in a countingvial togetherwith 10 ml of the toluene - Triton X - 1 (
scintillant and the radioactivity was determined with a liquid scintillati
counter . Blanks and totals were prepared as described in pp . 19 and
20.
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C . Determinationof Dextran - coated Charcoal Composition
Complete and rapid separation of the bound antigen from tre free so
that the radioactivityof either or both of these phases can be accurately
measuredis a requirementfor a good radioimmunoassay. In the adsorp c . i on
of free antigen with dextran - coated charcoal , too low a concentrationof
proteins and dextran will cause some of the antibody to be adsorbed , while
an excess often leads to decreased adsorption of the tagged antigen ( Skelley
et al . , 1973 ; Brock , 1973 ) . Therefore, a balancedporportions a pre -
requisite for a good separation.
( 1 ) Materials
[ 6 , 7 ( n ) - 3 H ] Oestradiol, 1 , 4 - bis [ 2 - ( 5 - pheny1 oxazo1 y 1 ) ] - benzene, dex_ tran,
gelatin, sodium, azide , Triton X - 100 , toluene, sodiumchloride, Worit - A , 2 ,
5 - diphenyloxazole, and anti - oestradiol were obtained from the sources
listedin p . 18 .
( 2 ) Reagents
PBS , assay buffer , 0 . 5 % gelatin solution, and toluene- Triton X - 100
scintillantwere preparedas stated in pp . 18 and 19 .
[ 3 H ] Oe s tradiolin assay bufferat a concentrationof 10 , 000 to 15 , 0 O 0
c . p . m . per 100 ul was preparedby dryingan aliquotof [ 6 , 7 ( n ) - 3 H ] oestradjol
And re - dissolvingit in enough assay buffer to give the desired conoentr , tion .
Dextran - coated charcoal suspensionsA through J were prepared by



































The frozen oestradiol antiserum (p. 19) was thawed and diluted with
60 volumes of ice-cold assay buffer.
(U) Method
Eighteen test-tubes (10 x 75 mm) (sample-blanks) each containing
100 jul- of fctiQ antibody solution ond [3h] oe stradiol solution were incubated
at U° for 16 hours. At the end of this period 1 ml each of the DCC suspen¬
sions A to J was added separately to two of the tubes and the contents
were mixed on a whirl mixer for 5 seconds. After standing in ice-water
for 10 minutesj the tubes were centrifuged at 3000 x g for 10 minutes.
A 1-ml aliquot of each supemate was placed in a counting vial and the
radioactivity was determined with a liquid scintillation counter after
the addition of the scintillant.
Blank controls were also prepared. Another set of 18 test-tubes
each containing 100 1 each of assay buffer and tritiated oestradiol solution
were similarly incubated for 16 hours. The addition of DCC and the deter¬
mination of radioactivity were carried out as narrated in the preceding
paragraph.
D. Determination of Nitrogen in Placental and Molar Tissues
The nitrogen content of placental and molar tissues was used as the
unit of reference in expressing oestrogen and progesterone concentrations
in these tissues. The micro-Kjeldahl method according to Wootton (196k)
was adopted.
(1) Materials
The following were obtained from E. Merck, Dramstadt, Germany:
sodium hydroxide, sodium tetraborate, broic acid, selenium dioxide, ethanol,
and sulphuric acid. Methyl red was supplied by British Drug Houses Ltd.,
Poole, Dorset, Gt. Britain. Methylene blue was obtained from the General
Chemical and Pharmaceutical Co., Ltd., Bradbury, Middlesex, Gt. Britain.
(2) Reagents
(a) Fifty per cent (vv) sulphuric acid with selenium dioxide. Fifty ml of
concentrated sulphuric acid were run into I4.O ml of distilled water in a
100-ml volumetric flask. One g of selenium dioxide was added and
shaken to dissolve. When cool, the volume was made up to the mark.
(b) Tashiros indicator. 80 mg of methyl red and 20 mg of methylene blue
were dissolved in 100 ml of ethanol.
(c) Boric acid-indicator solution. Twenty g of boric acid and 10 ml of
Tashiros indicator were dissolved in water to make 1 1. The pH was
adjusted to jj.8 with 0.1-M sodium hydroxide or hydrochloric acid.
(d) Sodium hydroxide solution. The solution contained k00 g of sodium
hydroxide per litre.
(e) 0.007-M sulphuric acid. O.k mi of concentrated sulphuric acid (96?,
wv) was added to 800 ml of distilled water, cooled, and diluted to
1 1. This solution was standardised with boric acid (Wootton, 197k).
(3) Preparation of Placental and Molar Tissues
—————a— I ——————in n ——a————— in I in I i i
Specimens were kept at ice-water temperature during delivery .to vhe
laboratory. C
Blood clots in molar tissues were removed by hand picking and washing
witn physiological saline. The tissues were then homogenised in water with
a Waring blendor for 3x1 minutes. The homogenate was lyophilised and
stored at u •
Umbilical cords and membranes were removed from the placentae which
were then cut into small pieces and washed with ice-cold physiological
saline repeatedly to remove blood. The tissue was then homogenised in the
same manner as molar tissues. Unused portions of the homogenates were
lyophilised for storage.
(u) Method
About 100 rag of the lyophilised placental or molar tissues were weighed
accurately with an analytical balance and digested with 2 ml of sulphuric
acid-selenium dioxide. Digestion took 0.5 to 2 hours to give a colourless
solution. The acid solution was washed into the still of a Pregl-Parnas-
Wagner micro-Kjeldahl apparatus (Baird and Tatlock Ghadwell Heathy Essex,
Gt. Britain). Ten ml of the sodium hydroxide, solution were added and the
ammonia in the sample was steam-distilled into 5 ml of boric acid-indicator
solution with the tip of the condenser immersed in the solution. When the
volume in the receiver had approximately doubled (10 to 15 minutes), the
receiver was lowered and distillation was continued for another minute.
The condenser delivery tube was washed with water down into the receiver
and the contents were titrated back to the original grey colour with
0.0C7-M sulphuric acid.
E. Determination of Oesiropens
Oestrogens were determined according to the method of Wu and Lur.dy
(1971).
(i ) Materials
[_6,7-tf] Oestradiol, 1 ,U-bis [2-(5-phenyloxazolyl)J -benzene , deziran,
gelatin, sodium azide, Triton X-100, toluene, sodium chloride, IJorit-A,
antibodies to oestradiol, and 2,5-diphenyloxazole were from the same sources
stated in p. 18.
Co, 7(n)-tl] Oestrone (specific activity 5U.3 Ciramol), [6, 7(0-1.] oestricl
(specific activity 53.1 Cimmol) were supplied by New England Nuclear Corp.,
Boston, Mass., U.S.A. Oestrone, oestradiol, oestriol, and Sephadex LH-20
were obatined from Sigma Chemical Co., St. Louis, Missouri, U.S.A. Benzene
and methanol of GR grade were obtained from E. Merck, Dramstadt, Germany.
Diethyl ether was of AnalaR grade and was obtained from British Drug Houses
Ltd., Poole, Dorset, Gt. Britain. Freshly opened bottles were u S6 O. £.; 1C.
unused portions were stored in full bottles. Antibodies to oestrone and
i
oestriol were from Biolab, Brussels, Belgium.
(2) Glasswares
Glasswares used in the assay were cleaned with chromic acid cleaning
mixture (Vogel, 1956), rinsed with glass-distilled water and dried in an
oven.
(3) Reagents
PBS, DCC, assay buffer, 0.5? gelatin solution, and toluene-Triton X-10C
scintillant were prepared as described in pp. 18-19.
(a) Recovery tracers. Aliquots of tritiated oestrone, oestradiol,, and
oestriol solutions were each diluted with methanol to a concentration
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of about 3,000 d. p. m. per 100 pl.
(b) Assay tracers. Aliquots of tritiated oestrone, oestradiol, and ce.:triol
solutions 4 ere evaporated to dryness and re-dissolved in assay buffer
to make a concentration of 10,000 to 1 , 000 c.p. m. per l00 ul.
All reagents except the scintillant were stored at 4°
(4) Antibody Solut ions
Antibodies to oestradiol were processed as in p. 21.
Oestrone and oestriol antibodies, obtained in lyophilised form, were
dissolved in 1 ml of assay buffer, snap frozen in small portions in 1-ml
serum, vials, and stored under deep freeze. They were thawed and diluted
with 9 volumes of ice-cold assay buffer before use.
(5) Oestrogen Standard Solution::
Standard solutions of oestrone, oestradiol, and oestriol were
prepared in methanol by serial dilution to give concentrations of 10 to
1, 000 pg per 100 pl.
(6) Preparation of Placental and Molar Tissues
Vide p. 2.25.
(7) Extraction Procedure
The extraction tubes were rinsed with fresh diethyl ether. One
hundred yl of each recovery tracer were added to the tubes and evaporated
to dryness with a stream of nitrogen. Another 100 ul of each recovery
tracer were added severally to counting vials and similarly dried. These
were later subjected to liquid scintillation counting together with the
tissue extracts for calculation of recovery. About 2 g of placental
homogenate were weighed into the tubes. In the case of molar tissues,
about 100 rag of the lyophilised tissue were used and 2 ml of distilled
-rater were added. The tubes were agitated with a whirl mixer. Extraction
was carried out with three volumes of ether three times. The extract was
washed with one-tenth volume of water twice. The ether extract was evap¬
orated to dryness with a stream of nitrogen. Washings with methanol dowse
the sides of the tubes helped to concentrate the extract at the tip of the
tubes. Water blanks, in which 2 ml of distilled water replaced the tissue
hom.ogenates, were also determined to monitor solvent impurities; the
ethereal solutions were processed in the same way as the tissue extracts.
The extracted oestrogens were subjected to purification on a micro¬
column of Sephadex LH-20. A slurry of 0.1+0 g of Sephadex LH-20, swelled
overnight in benzene-methanol (8$:15, vv), was packed into a 2-ml hypo¬
dermic syringe (internal diameter 9 mm). The column was washed with 7 ml
of benzene-methanol (1:1. vv) and 10ml of benzene-methanol (85:15).
The elution pattern of the column was checked with tritiated oestrore.
©estradiol, and oestriol.
The column was plugged and the residue after evaporation of oho
ether was transferred to the column with 2 x 100 I of benzene-methanol
(85:15). Tbe plug was removed and a no. 23 hypodermic needle was attached.
Separation of the three oestrogens was carried out as follows:
(1) 0.1 ml of benzene-methanol (85:15) was added to rinse the tube and the
eluate was discarded.
(2) 1.0 ml of benzene-methanol (85:15) was added to the column; the eluate
wa s di s c ar de d.
(3) 0.5 ml of benzene-methanol (85:15) was added to the column; the eluate
was collected (oestrone fraction).
(!+) 0.3 ml of benzene-methanol (85:15) was added to the column; eluate
discarded.
(5) C.8 ml of benzene-methanol (85:l5) was added to the column: eluai.e
collected (oestradiol fraction).
(6) 0.7 ml of benzene-methanol (85:15) was added to the column; eluafe
discarded.
(?) l.li ml of benzene-methanol (8515) were added to the column; sluate
collected (oestriol fraction).
The column was allowed to run dry between additions of eluant.
One hundred ul of each fraction was transferred to a counting vial
and evaporated to dryness. Five ml of the toluene-Triton X-10C scintillart
were added and the radioactivity was determined with a liquid scintillation
counter (Nuclease Chicago Mark I) to account for procedural loss during
extraction and purification.
(8) Radioimmunoassay
The assay was carried out in duplicate by adding benzene-methanol
(85:1$), methanol, standard oestrogen solution, and purified tissue
extract (diluted 10 or 100 times with benzene-methanol (8515)) to a



























aStandard solutions of oestrone (E.), oestradiol (E?), or oestriol (E„)
depending on the assay being carried cut.
All volumes were 100 jul unless otherwise stated.
After the addition of benzene-methanolj methanol standards a.nd extracts;
the contents of all the tubes were evaporated to dryness with a stream
of nitrogen. The antibody solution or assay buffer was added. The
appropriate assay tracer was added 30 minutes later and incubation was
carried out at Ii0 for 16 hours. When the incubation time was up5 1CC pi
of 0.$% gelatin solution were added to all the tubes and agitated to mix
the contents. DCC (1 ml) was added to all the tubes except the totals
and immediately agitated on a vortex type mixer. After standing in
ice-water for 10 minutes,, the test-tubes were centrifuged. in a refrigerated
centrifuge (Sorvail RC2-B) at 3000 x g for 10 minutes. One ml of the
supernate was transferred to a counting vial,, scintillant was added,, and
the radioactivity was determined with a liquid scintillation counter
(Nuclear Chicago Mark l).
F. Determination of Progesterone
Progesterone was determined according to the method of Cameron and
Scarisbrick (1973).
(1) Materials
Gelatin, sodium azide, dextran, toluene, Triton X-100, Norio-A,
O
[1, 2,6, 7 (n)-' H] progesterone, 1,Ii~bis[2-(5-phenyloxazolyl)]-benzene, 2,5-
diphenyloxazole, and antibodies to progesterone were from the sources
previously mentioned (p. 18).
Petroleum ether (b.p. l|G-60°) was of GR grade and was obtained from
E. Merck, Darmstadt, Germany. This was purified by passing through a
column (3 x 30 cm) of alumina (type I, GR grade, E. Merck) and re-distilled.
Ethanol (GR grade) was also supplied by E. Merck. Progesterone was obtained
from Sigma, Chemical Co., St. Louis, Mo., U.S.A.
(2) Glasswares
Glasswares were cleaned in the way described in p. 26.
(3) Reagents
PBS, DCC, assay buffer, 0op? (wv) gelatin solution, and toluene-
Triton X-100 scintillant were prepared as described in pp. 18-19.
(a) Recovery tracer. An aliquot of [3h] progesterone was diluted with
ethanol to about 3000 d.p.m. per 100 ul.
(b) 'Assay tracer. An aliquot of [ Hjprogesterone was evaporated to dryness
and then re-dissolved in assay buffer to give a concentration of
about 30,000 d.p.m. per 100 ul.
All reagents except the scintillant were stored at u°.
(5) Antibody Sc1ution
Rabbit antiserum to progesterone-11-hemisuccinate-bovine serur.
albumin was obtained in lyophilised form. It was dissolved in 1 mi
of distilled water, snap frozen in small portions in 1-ml serum vials,
and kept under deep freeze. The quantity required for the assay was
thawed and diluted with 50 volumes of assay buffer.
(5) Progesterone Standard Solution
Standard solutions of progesterone in ethanol were prepared by
serial dilution.
(6) Tissue Preparation
Placental and molar tissues were handled as described in p. 25.
(7) Extraction
One hundred 1 of the recovery tracer were added to the extraction
tubes and dried with nitrogen gas flow. Another 100 tul were transferred
to a counting vial, dried, and later counted with tissue extracts in a
liquid scintillation counter to account for extraction and procedural
loss. About 2 g of placental homogenate were weighed into the tubes. In
vhe case of molar tissues, about 100 mg of the lyophilised tissue were
weighed and 2 ml of distilled water were added. The tubes were agitated
to mix the contents. Extraction was effected with two ml of petroleum
ether and 1 minutes agitation on a vortex mixer. The tubes were
centrifuged in a clinical centrifuge to separate the aqueous and organic
layers. One hundred jul of the extract were transferred to a counting
vial, dried, and the radioactivity determined to allow for recovery
calculation. The rest of the extract was not purified as the antiserum
used in this determination was highly specific for progesterone (Niswerder,
1973).
(6 ) Radic-irrmunoassay
The determination was carried out in duplicate by adding the follow¬


























The extracts were diluted 10 or 100 times with petroleum ether.
All volumes were 100 ul unless stated otherwise.
After the addition of petroleum ether, ethanol, standards, and extracts,
the contents of all the tubes were evaporated to dryness with nitrogen
gas. Antiserum was added to the zeros, standards, and samples, and
assay buffer was added to the blanks and the totals. The tubes were
agitated and allowed to stand for 30 minutes. Then 100 U1 of assay tracer
were added to each, mixed, and incubated at l±° for 16 hours. At the end of
the incubation period, 100 1 of 0.5? gelatin solution were added and the
contents were mixed. With the exception of the totals all tubes received
a delivery of 1 ml of DCC. They were immediately agitated, stood in ice-
water for 10 minutes, and centrifuged in a refrigerated centrifuge (Sorvall
RC2-B) at 3;, 000 x g for 10 minutes to sediment the charcoal. An aliquot
(1 ml) of the supernate wis transferred to a counting vial and th
radioactivity was determined by liquid scintillation counting.
G. Se Germination of Cholesterol
ihe cholesterol content of placental and molar tissues was can emme a
according the method of Leffler (1959).
{1) Materials
Chloroform, ferric chloride hexahydrate, orthophosphoric acid (: 5 % •
wv), sulphuric acid (96-98%, wv), 2-propanol, and glacial acetic acta
were of OR grade and were supplied by E. Merer, Dramstadt, Germany.
Analytical grade anhydrous methanol was obatined from Mallinckred ChemicalV w V'
Works, St. Louis, Missouri, U.S.A. Cholesterol recrystallised from sohnoi
was supplied by Sigma Chemical Co., St. Louis, Mo., U.S.A. Sodium chloride,
A.E grade, was purchased from Ajax Chemicals, Sydney, Australia.
(L) Reagents
(a) Physiological saline. Nine g of sodium chloride were dissolved ner
litre of distilled water.
(h) iron stock solution. Ferric chloride hexahydrate (FeCl~.6H„0), J 'd
2.J g, was dissolved in 100 ml of phosphoric acid.
(c) Colour reagent. The.iron stock solution (8 ml) was diluted to ICQ ml
with concentrated sulphuric acid.
(d) Cholesterol standard solutions. A stock standard solution was
prepared by dissolving cholesterol in isopropanol to make a concen¬
tration of 1 rag per ml. Working standards of 0.2, 0.1, C.05, 0.025,
and 0.0125 Rigml were prepared by serial dilutions of the stock
standard solution.
(3) Preparation of Placental and Molar Tissues
Placentae and hydatidiform moles were processed as described in u. 25.
(U) Determination of Cholesterol
Total lipid extracts of the tissues were prepared by warming them
with 2d ml of chloroform-methanol (2:1, vv) and agitating. The mixture
£.3 filtered through filter paper previously moistened with chloroform.
The filtrate was washed by agitating with 10 ml of physiological saline
and centrifuge! to separate the layers. The upper layer was aspirated
and discarded and the major portion of the lower organic layer was filtered
through chloroform-impregnated paper. The filtered extract was diluted 5
no 10 times with isopropanol for the determination.
Reagents were added to polyethylene-stoppered test-tubes (6 x IgO
































The contents were mixed after the addition of acetic acid. Then 2 ml
of the colour reagent were carefully dispensed down the side of the
slanted tube to underlie the contents of the tube without mixing. With
the stopper in place, each tube was inverted four times and allowed to
stand for ten minutes. The absrobance was read at nm.
1.0
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Fig. 3. Curve produced with various oestradiol antiserum dilutioi
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Fib. 4. Curve produced with various progesterone antiserum dilutions in
screening for titre
RESULTS
A. Determination of Antiserum Titre
«rw«A-jr—•ci'.'i mrrwr.TjWirmm.MM!—nI nil inaa—iwtmT•;»:MjaHca
From the liquid scintillation data the ratio of radio-labelled ligand
bound to antibodies to free r o.dio-labelled ligand (the BF ratio) at each
dilution was calculated in t:e following manners
The 3F ratios were plotted against the number of times the antiserum was
diluted with assay buffer (i.e.5 the reciprocal of the anti-sorun dilution).
The plots for oestradiol and progesterone antisera are shown in Figs. 3
and h. The appropriate dilution is the one that will bind one half of
the radio-labelled antigen (BF - 1) in the absence of unlabelled antigen,
for5 at this concentration any change in the BF ratio can be most
accurfstelv determined.
The oestradiol and progesterone antisera showed a BF ratio of 1 when
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Fig. 6. Influence of Incubation time on the percentage binding of [f'H
progesterone to -antibody
B. Determination of Incubation Time
The percentage of radio-labelled antigen bound by the antibody was
studied as a time course and the percentage of radioactivity bound was
plotted against the incubation time. The percentage bound ($B) is given
by: 4
where x is thee.p.m. in the blank, y the c.p.m. in the sample-blank,
and z the c.p.m. in the total tubes. The results for the systems
[_ H]oestradiol-anti-oestradiol and [ progesterone-anti-progesterone are
shown in Figs. 5 and 6 respectively. Both systems exhibited the same
binding pattern. Binding was maximum after 3 hours and slightly
decreased on prolonged incubation. This decrease was not excessive,
being about in 10 hours. It can thus be inferred that incubation
damage is not a problem and 16 hours (overnight) incubation was chosen
as the most convenient duration.
C. Determination of Dextran-coated Charcoal Composition





















o 9! s a_ c. L-J
r f
ddOd













Over the wide range of dextran and I'Jorit-A concentrations studied., there
was no significant difference in the adsorption characteristics of the
LOG suspensions. The only odd-man-out was J whose high concentration
of charcoal adsorbed part of the antibody-bound oestradiol although noV c._.
significant lowering of the blank was observed.
D Determination of Nitrogen
The nitrogen content., expressed as a percentage of the dry weighty
of placentae was 13• In + 0.09 (17) (range 12.9 to 13-9) while that of•M
moles was 11.7 + 2.2 (11) (range 97 to 13.8). There is better
correlation between the nitrogen content and the dry weight in placentae«,
JSL
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E. Determination of Qestrogens and. Progesterone
The elution pattern of the micro-column used in the separation of
oestrogens is shown in Fig. 7. The fractions eluting between 1.3-1-8 (E ),
2.1-2.9 (E), and 3.6-5.0 ml (E) were collected and used for assay.
Liquid scintillation data were treated as follows. The per cent
bound (Y) was calculated as given in the following equation1
where s is the c.p.m. in the standard, b the c.p.m. in the blank, and
z the c.p.m. in the zero tubes. The logit transformation of Y was plotted
against the logarithm of the dose of standard antigen to give a linear
calibration curve. The logit transformation of Y is given by:
A typical calibration curve is shown in Fig. 8.
The concentrations of oestrogens and progesterone in placental and









63 i 31 (17)
233 + 112 (17)
990 + 383 (13)
36 + 38 (11)
hh+ 89 (11)
32 + 38 (11)
913 + 980 (11)
0.001 P 0.01
0. 2 P 0.3
P 0.001
0.8 P 0. 9
2L
Microgrammes per g-atom of nitrogen
Numbers in parentheses indicate the number of specimens studied.
Large variations occur in all groups (coefficient of variation 1|8 to 107$).
It is always with the molar tissues that a larger C.V. is observed,
probably reflecting the diversity in the degree of pathological change
and hydropic swelling. Analysis of these results with the Student's
t-test (Bancroft3 1957) shows that tho differences in the concentrations
of oestrone and oestriol are significant.
F. Determination of Cholesterol
The concentrations of cholesterol in placental and molar tissues
are tabulated belows




3108 + 866 (11 )
2$.9 + 7.6 (11)
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Expressed in rag of cholesterol per g-atom of nitrogen
b
numbers in parentheses indicate the number of samples studied.
Q
Expressed in rag cholesterol pe g dry tissue
cl
Expressed in mg cholesterol per kg of wet tissue
For comparison concentrations are also expressed on wet and dry
weight bases. Although lyophilised molar stocira@»-s were used throughout
the investigation the molar tissues were weighed before homogenisation
and lyophilisation and again after lyophilisation. This permitted
calculation of the wet weight when the dry weight was known. As dis¬
cussed on p. 50 the correlation between the wet weight and the dry weight-
is poor owing to variable degrees of pathologic degeneration and hydropic
swelling. In contrast3 there is good correlation between the dry weight
and the nitrogen content; placentae and moles contain respectively 13.it + H
0.09 and 11.7 + 2.2 per cent of nitrogen (p. Mi.)u
The Student5s t-test shows that there are significant differences
between the placental and molar concentrations when the results are
expressed on a nitrogen or a wet weight basis.
DISCUSSIONS
A. Determination of Antiserum litre
The antiserum concentration chosen for the present investigation
was the one that would give a bound to free ratio (BF ratio) of one
in the absence of untagged antigen. At this concentration the change
in the BF ratio is most pronounced and therefore most accurately
determined. For example, a decrease of %0% in the BF ratio from
an initial value of 1.0 is more easily determined than a similar
percentage decrease from an initial value of 10 or 0.1. In the first
case, there would be a decrease from %0% (BF = 1) to 33% (BF - 0.$)
whereas, in the second, there would be a decrease from 91%o (BF r 10)
to 83 (BF - 5), and in the third, a decrease from 9.1 % (BF - 0.1)
to h'Q% (BF r 0.09). In order to arrive at sensitive assays, oestradiol
and progesterone antisera were diluted to 60 and %0 volumes respectively.
B. Determination of Incubation Time
The length of incubation required by a radioimmunoassay depends on
the specific antigen being measured and periods varying from 30 minutes
to over a week have been recommended by literature on radioimmunoassay
technology (Lenz et al., 1975). The duration of incubation suitable for
the present systems was therefore investigated.
The time course studies showed that approximately 3 hours were
sufficient for incubation. Longer periods did not cause any deleterious
effects and choice can therefore be based on convenience. Longer perioaj
are preferable when large numbers of samples are analysed as they tend tc
lessen the difference between the first and the last tubes.
C. Determination of Dextran-coated Charcoal Composition
The adsorption efficiency of the DCC suspensions can be attributed
to the incorporation of gelatin which effectively eliminated adsorption
of antibody-bound antigen. Such findings were in agreement with those
of Brock (1973)- Hence the general practice of preparing radioimmuno-
assay reagents with gelatin or bovine serum albumin solutions.
Since A through H were equally effective as far as separation of
bound and free antigen was concerned the choice of DCC composition
followed the general consensus, and B was employed, in the present study.
D. Determination of Nitrogen
The nitrogen content of the placental and molar tissues was determined
to serve as a basis for expressing the concentrations of steroid hormones
in these two tissues.
Wet weight cannot be used as the basis of expression as placentae
are compact but moles mostly consist of fluid-filled vesicles (Barak
1970). Different moles also differ in their water content; they show
varying degrees of pathological degeneration and extent of hydropic
swelling. The nitrogen content was therefore determined to serve as a
basis of comparison.
Table 1
Values found bv different authors for oestrone. oestradiol, and oestriol in placental and molar tissues
A 4» U -I.-
P.hflmhprl an n p.t al - ( 1 968 )
Hnnt.+.c! =+. p! . f 1 OA Q 1
Diczfalusy et al. (1961)
Huffman et al. (19U0)
Jackowickiet al. (1973)
Mitchell and Davies (195U,
Schild (1961)
Schmidt-Elmendorff (1961 )
P-po o -n+. n rrrro q+. n crp h 1 nn


















































aConcentrations expressed in u.gg-atom of nitrogen
flnnf.fintrabions exoressed in tizkg wet weight
Table 2
Values found by different authors for progesterone in placental and molar tissues (jugkg)
PI 3 r»-n+ Q Hydatidiform
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E. Determination of Oestrogens, Progesterone, and Cholesterol
Since the oestrogens cross-react with the same antibody, separation
with column chromatography is necessary. Elution is in the order:
oestrone, oestradiol, and aestriol, showing that the more polar hydroxyl
groups the compound possesses, the later it elutes from the column.
The peaks slightly overlap (Fig. 7) so the fractions collected were
those that include the main portion of each compound) any loss in this
and other steps will be accounted for by the recovery tracers. The
progesterone extract was not purified as the antiserum, raised against
a C—11 conjugate, was resorted to be highly specific (Miswender, 1973).
In all of the four hormones analyses, the molar tissue is always
the one which shows a lower concentration, and the differences are
significant in two of the cases. There are large variations in the
steroid concentration between specimens. Variations, as a result of
different degrees of contamination with blood can be ruled out, for,j j
during pregnancy, the plasma concentration of oestrogens is less than
10 fig per 100 ml and that of progesterone is less than 30 yg per 100 ml
(Kutsky, 1973). The values reported by other authors are listed in
Tables 1 and 2. It can be seen that agreement is poor and Mitchell
and Davies (19$h) also remarked that he found large differences among
individual specimens. These can be attributed to biological differences
as well as to the different extents of pathological change in the molar
tissues: the moles were removed after variable periods of gestation.
It should be noted that a variety of methods were used in these
investigations. Even one and the same method used by a single author
also gave different results for different specimens. The finding of
Dawood (1975) is of interest. Contrary to other reports, he obtained
a much higher progesterone content in molar tissue than in placentae.
His explanation was the accumulation of progesterone in molar vesicles
in the absence of a circulation. If this is true, the reasons that
lead to the accumulation of this steroid would also inhibit the supply
of presupsors and hence a reduced rate of synthesis (Botella-Llusia,
1973)- In his previous communications (Dawood et al», 197h} Dawood, 197bj
Teoh et al. , 1972), Dawood's group remarked that hydatidiform mole
was a hyperplastic disorder with a hyperactive steroidogenic activity
when they discovered that the serum progesterone and oestradiol levels
ware higher in molar pregnancy than in normal pregnancy of a comparable
duration. This hypothetical augmentation of ovarian synthesis by the
molar tissue is unlikely to be true if progesterone can accumulate in
the nolar tissue and at the same time is shuttled to the general
circulation. Cholesterol is a precursor of progesterone. It is not
synthesised de novo in molar tissue. The cholesterol level was therefore
determined. Expressed on a wet weight basis the lower molar concentration
may signify reduced steroid production and may lend support to the
present finding. On a dry basis the molar cholesterol is higher but
its effect may not be enough to offset these of reduced precursor supply
and uterine blood flow, both being consequences of the death of the
foetus. The present investigation also differs from Dawood's (1975)
in the method employed. Antibodies used in radioimmunoassays show
greater specificity than the plasma proteins employed in competitive
protein-binding assay.
As Van Leusden and Villee (1966) pointed out, placental or molar
tissues are unable to carry out the de novo synthesis of oestrovensumb—ammuam - - - —
or progesterone, and they have to be supplied with suitable precursors
like cholesterol or pregnenolone. The trophoblastic tissue utilises
DHEA sulphate of foetal origin for oestrogen biosynthesis, but in the
absence of a foetus in hydatidiform mole, this steroidogenic circuit
cannot be set up The importance of the foetal contribution can be
seen from the lowered oestrogen output encountered in foetal death
and anencephalic monsters, and in ligation of the cord (Cassmer, 19b9) -
Conversely, an increase in oestrogen excretion is seen in congenital
adrenal hyperplasia (Oathro et al., 1969a, 1969b).«• wa --»,i Ktgsmctsm
Despite a decreased level of foetal adrenal steroids, the mole
is equipped with aromatising enzymes, isomerases, and 33-hydroxy~
steroid dehydrogenase (dacKay-Hart, 1966), and is capable of oestrogen
synthesis if it is equipped idth the necessary precursors (Van Leusden
and Villee, 1966). In short, all the indications are that the potential
for steroidogenesis remains intact in benign molar tissue but the
absence of functioning foetal adrenals results in a low oestrogen
output (Botella-Llusia, 1973d The lower oestrogen output is reflected
in the activity of -glucuronidase (Leung, 1976). This enzyme is
responsible for the cleavage of steroid glucuronates to facilitate
their passage across the placental membranes (Levitz, 19661 Levits
and Dancis, 1963) There is a lower activity and disappearance of
an isoenzyme form in molar tissue preparation (Leung, 1976). The
additional isoenzyme form seen in the normal placenta may be elaborated
to meet with the foetal production of steroid conjugates. The lossnim Vg V '
of an isoenzyme form in molar tissue may be explained as a reflection
of the lower steroid level. It should be pointed out that this enzymeX £
system is sensitive to serum level of sex steroids $ Edlow et al. (1971)«.~Mf»imnra-i
observed an enzyme activity similar to that of pregnant women in sub¬
jects taking contraceptive steroids. Leungs observation (1976) of
lower activity in molar serum offers support to lower oestrogen
levels in molar tissue,
Stitch et al. (1966) pointed out that progesterone synthesis takes
placo in the trophoblastic tissue. As progesterone synthesis is not
dependent on foetal precursors (Fig. 2)3 the level of this steroid
in molar tissue may approximate that of the normal placenta. However9
the level can still shorn a slight lowp forp in hydatidiform mole with
the disappearance of the foetus5 there is a re action of the circulation
and hence the supply of precursors (Botella-Llusia, 1973). 7ho present-
study shows that this indeed is the case; molar and placental tissues
show approximately the same progesterone concentration when it is
expressed on a nitrogen basis. O11 a wet basis the molar tissue shows
a lower concentration but it shou3.d be reiterated that comparison on
a wet weight basis is not justified. It has been mentioned in p. pO
that molar tissues show different degrees of hydropic swelling owing
to the variable degrees of pathologic change. Although other authors in¬
variably used the wet weight as basis5 this was actually not a sound
unit of reference for reasons mentioned above.
It is well-known that HOG possesses steroidogenic activity. The
high urinary and tissue levels in molar nregnancv and a low steroidC J- v_w. €
level in molar tissue may be an indication that the molar tissue Itself
Is probably not the target site for gonadotrophic action.
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SUMMARY
Gross endocrine disturbanced have been observed in the placental
disorder known as hydatidiform mole. The most prominent clinical
condition is a highly enhanced cutput of urinary chorionic gonadotrophin,
which has an effect on steroid biosynthesis and metabolism. It is
therefore interesting to compare the levels of steroid hormones in
hydati diform mole and normal placenta. Radioinmunoassay was used because
it permits quantitation of substances at concentrations in which they
are actually present in biological specimens and is more specific. The
results show that molar tissues contain significantly less oestrone and
oestradiol. The lower concentration is accompanied by a concomitant
decrease in the activity of p-glucuronidase (Leung, 1976). which is
elaborated in pregnancy for the hydrolysis of steroid conjugates. The
high -1'CG level combined with a low steroid concentration in molar
tissues may be an indication that the molar tissue is not the target
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APPENDIX
During the survey of literature numerous reports have been found
dealing with oestrogens and progesterone under various pathological
conditions. In order to give a more complete picture of there steroid
hormones, such information is appended here.
A. Oestrcgens in Pathological Pregnancies
Of the urinary oestrogens, oestriol is excreted in the largest
quantities in human pregnancy. Although it has been proposed that the
foetal state is more accurately indicated by determinations of oestetrol
(oestra-1, 3, 5 (10)-triene-3, 15a, 16a, 17/3 -tetrol), 11-dehydro-17a-oe stradiol.
and 15-hydroxyprogesterone, which are derived mainly from foetal precursor
(D.iczfalusy et al., 1971), data concerning them in normal and pathologica_
conditions are still wanting. Oestriol excretion is undoubtedly altered
in pathological pregnancies. Authors like Van Leusden (1972), Josimovich
(1973), Kaplan (1972), Scommegna (1968, 1969), Stitch (1972), Taylor et
al. (1965a,. b), Ostergard- (1973), Brinck-Johnsen and Benirschke (1968),
rcevedo et al. (1968), Aleem et al. (1969), Biggs (1975). Booth( 1965),
Greene and Touchstone (1963). and Wei et al. (1968) have reviewed or
given the statistical values of oestrogen determinations in pregnancy.
A decreased excretion might be related to diminished enzymatic activity
and/or a decrease in the availability of precursors. Even if the
collection of urine is complete and technical errors are excluded, there
are wide variations from day to day and from one individual to another
and the oestrogen/creatinine ratio has been proposed as a practical and
reliable index of foetal welfare (Aubry et al., 1975). Clinically a
decrease in oestrogen excretion is mostly caused by generalised disturb-
ances in the foetus and placenta. Among the organs involved are the
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foetal hypothalamus and pituitary, adrenals, liver, trophoblast, and the
maternal kidneys (Liggi ns, 1972).
(1) Abortion
Oestrone and oestriol excretions were found to decrease prior to
the expulsion of the conceptus or before the abortion manifested itself
(Booth et, al., 1965; Klopper and Macnaughton, 1965; Brown et al., 1970).
Bengtson and Forsgren (1966) found a low oestriol excretion in missed
abortion. However, Wei et al. (1968) discovered that oestriol values
could not predict the outcome of pregnancy in threatened abortion in
mere threatened abortion or abortion due to cervical incompetence (Booth
et al., 1965). oestriol excretion was usually in the normal range.
Most authors (e.g., Diczfalusy and Borell, 1961; Rebbe and Moller,
1966) agreed that urinary oestriol did not change after bilateral oophor-
ectomy in early pregnancy. Hence lowered oestriol excretion in abortion
is caused not by changes in therrother but by changes in the foetoplacental
unit.
(2) Choriocarcinoma
Investigators like Payne (1941) found an increase in oestrogen
excretion in choriocarcinoma. Barlow et al. (1967) found that the
in vivo conversion of DHEA sulphate into oestrogens occurred in only
four out of twelve women with malignant trophoblastic disease and he
concluded that the conversion was characteristic only of the benign
trophoblast. However, in vitro experiments showed that a case of
choriocarcinoma, like preparations of hydatidiform moles and of normal
placentae, was capable of converting pregnenolone into progesterone and
of carrying out the aromatisation of DHEA into oestrone and oestracli.ol.
It also showed side-chain cleavage in vitro, in contrast to molar and
normal placental tissues (Van Leusden, 1972). These in vitro findings did not
seem to support the theory that choriocarcinoma results from hydatidiform
mole since chorioepithelioma apparently possesses more enzymatic properties
than hydatidiform mole does. A hypothesis that may explain this observation
is that choriocarcinoma arises ere differentiation of the fertilised ovum
into rrophoblast and foetal cells strictu sensu takes place (Van Leusden,
1972). However, Telegdy et al. (1970) showed that the human mid-gestation
placenta did possess an ability, although quite limited, to synthesis
cestradiol from cholesterol. The above theory on the origin of chorio¬
carcinoma should, therefore, be viewed with caution.
(3) Abdominal Pregnancy
When abdominal pregnancy is terminated by Caesarean section with
the placenta left in situ, there is a sharp decrease in the ratio of
oest-riolt (oestrone + oestradiol), but the excretion of pregnar.edicl is
not affected (Booth et al., 1965)- This illustrates that the foetus
contributes significantly to maternal urinary oestricl formation.
(1:) Anencephalic Monsters
In anencephalic pregnancy there is hypoplasia of the foetal
adrenal cortex and functional inadequacy of the foetal zone of the
adrenal cortex owing to the absence of the foetal hypothalamus and an
insufficiency in the secretion of ACTH (Liggins, 1972).
Anencephalic pregnancy is characterised by a low serum level of
oestricl (Cleary and Young, 197U) and very low amounts of A-35-hydroxy
sieroids (e.g., DEEA sulphate and 16-hydroxy-DHEA sulphate) in the blood
of anencephalic monsters (Eberlein, 196) although the capacity of the
placenta of anencephalic monsters is the same as normal placentae
(Schindler and Ratanasopa, 1968; Aleem et al., 1969), a direct conseouence
cf the morphological under-development of the foetal adrenal cortex,
especially the foetal zone. The small amount of oestrogens that is formed
by the placenta is derived from maternal DKEA sulphate.
Since oestriol is relatively a specific product of the foetal
adrenals whereas oestetrol is claimed specific to the foetal liver (Dicz-
falusy et al, 1571 ), a study of oestetrol excretion in anencephalio
pregnancy would pose new interest.
(5) Adrenogenital Syndrome
It could be argued that since adrenocortical hypoplasia entailed
a low oestrogen production, adrenocortical hyperplasia of the foetus likely
caused elevated excretion of oestrogens. In this condition there is a
deficiency in the 1 la-hydroxylase or 21a-hydroxylase systems, resulting
in a subnormal synthesis of Cortisol. Consequently, ACTK secretion is
increased and the level of DHEA sulphate, precursor of oestrogens, is
elevated. In a case of a mother bearing a girl virilised with congenital
adrencortical hyperplasia, Cathro et al. (I969a b) found very high
values for oestriol excretion. It is suggested that amniotic fluid 17-
ketost-eroid (Merkatz et al.. 1969) ad pregnanetriol concentration at
term (Jeffcoate et al., 1965; Merkatz et al., 1969; Nichols, 1969;
Nichols and Gibson, 1969; New, 1970) are elevated when foetuses are with
congenital adrenogenital syndrome.
(6) Foetal Sex
The correlation between foetal sex and maternal oestriol excretion
has not been reported, and no difference in the concentration of oestrogens
in the first voided urine of male or female newborn infants has been
found (Dickey, 1960; Dickey and Robertson, 1960).
(7) Multiple Pregnancy
The majority of investigators (Borth et al., 1959; Keller et
al., 1959; Beischer et al., 1968a, .1968b, 1968c). found increased
excretion of oestrcgens in multiple pregnancy as compared with normal
pregnancy, but Wei et al. (1968) found normal oestriol excretion in
subjects bearing twins and triplets.
(8) Hypertension
Aubry and Nesbitt (1970) found that in hypertension and pregnaney
without superimposed toxaemia and with a normal viable foetus, the
excretion of oestriol is in the normal range. However, if only the
severe hypertensive group of patients (blood pressure greater than '•6 0110)
is considered, the mean oestriol tends to be low, especially beyond the
26th week of pregnancy. The cause is possibly due to a lower near,
foetal weight in this group.
Oestriol is usually below the normal range in pre-eclamptic toxaemia
(Bjoro, 1972; Oakey et al, 1967). Keller et al. (1959) fourd only a wider
scatter than normal.
Taylor £t al. (1958) and Duhring and Greene (1966) found a correlation
between the severity of toxaemia and the lowering of oestriol excretion.
The cause of the lowering is attributed to the microscopic placental alter
ations, reduction of uterine blood flow, and decreased placental and
foetal weieht (Taylor et al., 1958; Breborowicz et al., 1965; Bjoro, 92)
[9) Rhesus Incompatibility
Banerjea (1962), Taylor et al. (1963)5 Klopper and Stephenson (i960),
Lundvall and Stakemann (1969)5 Heys et al. (1969)5 and Samaan et al. (1969)
found normal to high-normal values of oestriol excretion in Rh iso-
immunisation.
Klopper and Stephenson (1966) did not regard oestriol as reflecting
the foetal status, a decrease being observed only after intra-uterine
foetal death, and is therefore not helpful in the management of oregnancy
complicated by Rhesus incompatibility, but Mandelbaum and Evans (969)
and Mandelbaum et al. (1970) did not share this opinion. Even in the
presence of hydrops foetalis or within one or two days of foetal aea~u,
oest-riol excretion is inside the normal range, and a decrease is ferns
only within twenty-four hours of intra-uterine death (Schindler et al.,
19c7). There is no relation between the degree of foetal damage and the
level of plasma nestriol (Schindler et al., 1967; Ratanasopa et al. ,
1967).
There is a marked decrease in urinary oestriol immediately after
intra-uterine transfusion (Bjerre et al., 1968; Dickey et al ., 1963:
Carpenter. 1970). The cause of this is not known. TTsually the excretion
returns to normal after a few days and from this time on its value mayt C
be used as a guide for the assessment of the foetal condition (Bjerre e_o
al., 1968; Carpenter, 1970; Mandelbaum et al., 1970). Persistent lew
values are an indication that the foetus has succumbed (Liggins, 1972.
Severe Rh isoimmunisation has been found to be associated i~h lew
or non-detectable amniotic fluid oestriol (Schindler and Hermann, 966 r
Schindler and Ratanasopa, 1968: Aleem et al., 1969), l6-ketoandrc=tenedicl,
and l6a-hydroxy~DHEA. (Schindler and Ratanasopa, 1968). However, vhe
concent-rations of DHEA and pregnanediol in amniotic fluid do not apr-ear to
be altered unless the foetus has alreadjr died (Schindler and Ratanasopa,
1963).
A correlation has been established between amniotic fluid cestricl
and bilirubin and the amniotic oestriol value is claimed to reflect the
condition of the foetus better than maternal plasma or urinary values
(Schindler et al., 1967). Oestriol glucuronide is excreted into the
amniotic fluid via the foetal urine and the concentration of this
conjugate reflects to a large extent the enzymatic activity involved
in glucuronic acid transfer in the foetus. Lowered amniotic fluid oestriol
therefore signifies foetal liver damage in Rh isoimmunisation
(10) Maternal Diabetes
Oestrict has been reported to be higher than the normal range
(Samaan et al., 1969; Klebe -£t al. , 197U) in the lower limits of
the normal range (Schindler and Ratanasopa, 1968; Hobkirk ejt al.,
1960; Hobkirk and Nilsen, 1962; Coyle and Brown, 196.3; Green et al, ;
1965; Taylor ejt al. , 1 96pa, b; Persson et al. , 1 973) or in ti e
normal range (Laur.itsen and Lebm.unn, 1971) in diabetic pregnane;.
Aubry and Nesbitt (1970), and Bolognese et al. (1971) found :3strict
excretion below the normal range in diabetic pregnancy complicated by
hypertension.
Plasma oestriol is in the normal range (Cleary and Young, 197t;
Roy and Krr, 196I4.) or lower than normal (Ratanasopa et al., 19-7).
DHEA sulphate is mostly a uteroplacental clearance. If the diabetic
pregnancy is not complicated by toxaemia,, umbilical arterial DHEA snlpnate
and i6-hydroxy-DHEH sulphate are normal. However, in.
vitro experiments have shown that the aromatisation of DHEA into cestrone
is affected (Lauritzen and Lehmann, 1971; Van Leusden, 1972). Sinoe the
oestrogen and DHEA values are usually normal, some factors must condensate
for this placental defect. This may well be the hypertrophy of ohs placenta
(Van Leusden, 1972).
Schindler and Ratanasopa (1968) and Bolognese et al. (1971 ) recorded
amniotic fluid oestriol to be low or undetectable.
Beling (1971 ) is singular in regarding urinary oestriol as an important-
factor in deciding the appropriate time for the induction of labour, but
this opinion is not shared by others. Intra-uterine death of the lare CO
foetus may occur at or beyond term in the presence of normal or even high
oestriol. Normal oestriol levels are therefore not an encouragement bo
prolong pregnancy beyond the time when other clinical indications point
to the desirability of delivery (Liggins, 1972).
(11) Foetal Weight and Retarded Foetal Growth
In the absence of recognisable maternal disease, retarded iserer grov; n
is always accompanied by a low oestriol excretion (Yousem et ai., yto j
Wallace and Michie, 1966; Bell et al. , 1967; Oakey et al., 1967; iycsgar,
19685 Be is cher et al., 1968a, b, c; Keys et al., 196-9; Greene ey el,, 969;
Bjoro, 1972). If the retardation of foetal growth is the result of
obstetrical maternal disease like pre-eclamptic toxaemia, the oestrogen
excretion is also on the low side (Bell e_t al., 196-7; Nerll and -.ocafee,
1966; Anbry and Nosbitt, 1970).
Most authors (lan and Ambrose, 1972; Greene and Touchstone, 1963;
Coyie and Brown, 963, Yousem e_b al., 1966; Neill and Macafee, '968:
Beischer et al., 1968a, b, c; Easter-ling and Talbert, 1970; Aubry and
Nesbit-t, 1970: Anonym, 1976.) found a correlation between foetal weight and
oestriol excretion in pregnancy, but Klopper and Billewicz (1963) reported
that no such relationship could be demonstrated. Increased placental
mass in conditions like diabetes and Rh isoimrnunisation is accompanied
by an increased oestriol excretion which may mask the clinical cc.-.diuicn
of the foetus.
Amniotic fluid oestriol concentration is also correlaued with foetal
weight (Aleem et al., 1969). From the practical point of view it is true
that serial assays of oestriol is of value in establishing foetal growth
retardation, but, when the oestriol value is low, retardation is so
advanced that oestriol determinations are of little additional value
(Booth et ai., 1965).
'12) Foetal Acidosis
A relation is established between urinary oestriol excretion and
foetal acid-base status in high-risk pregnancies. About of this
group has pH values less than 7.2 and the oestriol excretion is below
normal limits in about (Beard et al., 1966; Fliegner et al. , '969;-
(13) intra-uterine Death
Urinary oestriol shows a pronounced drop after foetal death
(Bengtsson and Forsgren, i966). The general consensus is that when the
oestriol values are below 2.0 to U-0 rng per 2a hours after the 33rd week .
it portends imminent foetal death (if it has not already occurred)
(Greenej 1970).
(lU) Anaemia
After week 30 of pregnancy urinary oestriol values are below the normal
range in approximately 25% of patients whose haemoglobin level are below
100 gm per 100 ml (Beischer et al., 1968a, b).
(15) Antepartum Haemorrhage
Normal oestriol values are found in placenta praevia (Beischer _et al.,
1967) and low or slightly subnormal values are found in other causes of
bleeding (e.g., minor placental abruption) (Beischer et al., 19671 Bjoro,
1972). However, normal urinary oesuriol values are no assurance against
imminent severe placental abruption (Beischer et. al., 1970).
Dickey (1969) found that the oestrogen:creatinine ratio of infants
born following pregnancies complicated by maternal haemorrhage are
significantly below the average for normal infants.
(16) Prematurity
Taylor et al. (1965a, b), Bolognese et al. (1971), nd Campbell and
Kurjak (1972) found lowered oestriol excretion in prematurity. Aubry
and Nesbitt (1970) reported that the oestriol excretion is below the
normal range as early as the 2l|th week of pregnancy in patients wrho had
repeated premature births (patients who had delivered two or more infants
with birth weights between 1,J00 and 2,50C g in the past).
As previously mentioned, there is a correlation between foetal weight
and cestriol excretion. Hence, if we define prematurity as low birth weight,
oestriol is low as compared with the group bearing -with normal birth weight.
However, if prematurity is defined in terms of duration of pregnancy,
oesoriel excretion is not necessarily lowered.
(17) Onset of Laoour
Very often there is considerable post-maturity in cases of
anencephaly with polyhydramnios. The foetal adrenal cortex is absent or
underdeveloped in these anencephalic monsters. In contrast, Turnbull and
Anderson (1969) discovered that many infants delivered as a result of
so-called unexplained premature labour after week 20 had greatly
increased foetal adrenal weight.
Urinary oestrogen analysis shows that at week 3b of pregnancy,
patients with high uterine activity and early onset of labour have a high
oestriol and a low oestrone. Pregnanediol is not related to the gestational
length at the onset of labour (Turnbull et al., 1967). These data strongly
1 • -
point tc the existence of a foetal mechanism acting as a signal fcr the
onset of labour, involving the foetal hypophysis, hypothalamus, and adrenals,
and, possibly, oestrogen synthesis in the foetoplacental unit as well.
(16) Prolonged Pregnancy and Post-maturity Syndrome
Generally prolonged pregnancy is defined as one that is more than
fourteen days post term. (By term it is meant 280 days after the first-
day of the last menstrual period.) Although the possibility of pseudo-
prolonged pregnancy due to retarded ovulation exists, it has been well
established that part of the prolonged pregnancy foetuses have a post¬
maturity syndrome manifested by reduced liquor arnnii, meconium staining,
and desquamation of the skin and an associated high perinatal mortality.
Placental insufficiency consistent with foetal survival to terr. and
which nay go unrecognised may prove lethal if the pregnancy is allowed
to go two or three weeks beyond term. Liggins (1972) suggested teas all
post-term expectant mothers should be screened at U2 weeks and induce!cr
of labour be carried out if the oestriol is less than 12 rng per day. In
this case transabdominal puncture for amnioscopic observations ana fluid
analvsis nav be more useful than serial oestriol determinations although- —
an increasing oestriol excretion may often be used to add support f:
putting off the induction of labour as long as the amniotic fluid dees
not become meconium-stained (Van Leusden, 1972).
B. Progesterone in Pathological Pregnancies
Aceve do et al. (1968) found a parallelism between pregnanetriol
and total oestrogen excretion on the one hand and between pregnar.clone
and pregnanediol on the other in both normal and pathological pregnancies.
Fotherby et al. (196$) was unable to establish a relationship between
pregnanediol and pregnanetriol excretions. The general picture is erst
the foetus contributes less to the progestational steroids and the levels
of these steroids reflect, more of the maternal and placental status rather
than that of the foetus.
(1) Abortion
Yoshimi et al. (1969) observed that plasma progesterone and 17a-
hydroxyprogesterone reached a peak at about three to four weeks after
ovulation. The progesterone concentration reached its nadir at six to
eight weeks and then rose again but the 17-hydroxyprogesterone concen¬
tration continues to decline. Since the placenta has limited capacity for
17a-hydroxyprogesterone, these findings suggest that the first peak reflects
the function of the corpus luteum while the second peak not containing
17a-hydroxyprogesterone reflects placental function. This conjecture
rained The support of Holmdahl et al. (1971) who showed that therapeutic
abortion before week nine of pregnancy was accompanied by slowly declining
levels cf progesterone in the plasma, indicating that the corpus luteurn va:
still carrying the lion's share of the secretion. In contrast, abortion
between weeks twelve and sixteen resulted in a rapid decline, suggesting that
the rlacenta was the chief organ producing progesterone by this time. When
the placenta has Taken over the job of progesterone secretion, the ovaries
can be dispensed xith and ovariectomy does not necessarily result in
abortion. Brown et al. (1970) reported successful pregnancies in patients
ovariectomised when they were h9 or more days pregnant, and no interference
with pregnanediol excretion, the progesterone metabolite usually taken as
an index of placental progesterone production, was observed. In actual
abortions, the pregnanediol excretion is lowered, but normal excretion
will be obtained if the abortion was only threatened (de Watteville,
1 1; Acevedo et al., 1968, 1969; Brown et al., 1970). Russell et al.
(1957j 1961) measured the pregnanediol excretion in pregnant women
threatening to abort and found no difference between the group which did
1
abort- and that which did not. Although normal pregnanediol excretion is
not- always correlated with a favourable outcome, there is usually, but
not always, a correlation between-low preganediol excretion and poor
prognosis.
The common reason for abortion is a defect of the germ plasm, and
progesterone deficiency is but a secondary effect of foetoplacental damage.
The use of progestogens in the treatment of habitual abortion is of no
true value (Csapo, 1958).
(2) Choriocarcinoma
An increased excretion of pregnanediol in choriocarcinoma xas found
by Payne (19U1 ) - Human choriocarcinoma tissue can synthesise progesterone
fr omCia'-H-kregnenolone (Huang et al., 1969)- This progesterone nay
contribute to ohe pregnanediol excreted by patients with choriocarcinoma.
• m n 1 J O 1 1 i
[Progesterone,l H- Cjandrostenedione,L H- Cjtestosterone
y i
pH-1c]oestrone, andjpH- Joestradiol were produced by fresh choriocar-
Kpregnenolone and f uc]DHEA. Hence, unlike
the molar trophoblast, choriocarcinoma can convert C-21 to C-19 steroids.
These findings seem to disprove the hypothesis that choriocarcinoma
would arise from molar trophoblast (Van Leusden, 1 972).
(3) Abdominal Pregnancy
If the placenta is left in situ after the termination of an abdominal
pregnancy, considerable amounts of pregnanediol can still be found in the
urine for several weeks (Friedman et al., 1969). The plasma progesterone
levels in such an experiment shows a slow decline indicative of a slowly
waning production rather than the metabolic clearance of progesterone.
(u) Anencephalic Monsters
Friedman and Stakemann (1966) found normal excretion of pregnanediol
in pregnancies with anencephalic monsters. The foetal adrenals contribute
little or none to the excretion of progesterone or pregnenolone sulphate
since ligation of the umbilical cord or the occurrence of a real knot
in the cord produced hardly any change in the pregnanediol excretion
(Cassmsr, 1959).
(5) Multiple Pregnancy
The level of progesterone goes up with the number of foetuses
(Short, 1969). Progesterone, output is. correlated with placental weight.
(6) Hypertension
In the severe hypertensive group (blood pressure greater than 180100),
a normal outcome is accompanied by a slightly lowered excretion of preg-
naneaiol (Aubry and Nesbitt, 1970). Impending foetal death is net aivrays
signified by a lowered pregnanediol excretion (Coyle et al., 19o2) and
foetal prognosis is not correlated with pregnanediol excretion.
Acevedo et al. (1968) pointed out that total oestrogens and pregranetrio]
would represent an index of the status of the foetal compartment of the
foetoplacental unit after adrenal differentiation has taken place,
and urinary pregnanediol would represent an index of the progestational
activity of the placenta (or the corpus luteum in the early stages of
gestation). In toxaemia of pregnancy foetal impairment is only secondary
to placental impairment, and pregnanediol excretion in pre-eclamptic
toxaemia has reported to be in the normal range.
(7) Rhesus Incompatibility
Klopper and Stephenson (1966) and Samaan _et al. (1969) found normal
pregnanediol excretion in rhesus incompatibility. The amniotic fluid
pregnanediol is also in the normal range unless the foetus has succumbed
(Schindler and Rtanasopa, 1968). The measurement of pregnanediol is there¬
fore of little or no value in the management of isosensitised patients.
(8) Diabetes Mellltus
The excretion of pregnanediol is in the upper region of the normal
range (Samaan et al., 1969j Aubry and Nesbitt, 1970), probably owing to
the greater mean placental weight in diabetic pregnancy. No correlation
between pregnanediol excretion and impending foetal death were found by these
authors.
(9) Foetal Weight and Retarded Foetal Growth
There is no unanimous opinion regarding foetal weight and pregnanediol
excretion. Shearman (1959) found insignificant pregnanediol excretion
with foetal weight.
In retarded foetal growth in the absence of recognisable maternal
disease., pregnanediol excretion is low (Aubry and Nesbitt_, 1970). The
lowering is not so marked as in the case of oestriol.
Although progesterone is clinically not as significant as oestrogens
in the management of pregnancy and its concentration and excretion reflect
to a lesser extent the condition and outcome of pregnancy5 it is the
steroid hormone produced in the largest quantities in the months of
gestation.
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